Pistoia Alliance

We’re looking for 🔊 speakers for our annual London conference at the Royal Society of Medicine, 25-26 March, 2025. We are excited to announce the theme of our conference is Data Driven Innovations. If you are a thought leader in life sciences R&D and have valuable insights or a case study to share with our community on key topics including AI, Real World Data and how data can accelerate the delivery of new breakthroughs, please get in touch with any of the following Pistoia Alliance team: Becky Upton, J Christian Baber, John Wise, Thierry Escudier, Vladimir Makarov, Catherine Maskell, Shaun Tamblin, Cristina Fasca or 📧 email comms@pistoiaalliance.org #collaboratetoinnovate #collaborationthatdelivers #bettertogether

Our Pistoia Alliance survey with Copyright Clearance Center (CCC) , found that 83% of life science professionals now use #GenAI in their research, but concerns about the impact of AI and copyright remain. Find out more in The Medicine Maker here: AI and the Copyright Question for R&D https://lnkd.in/ejemC3GV

Merry Christmas from all of us Pistoia Alliance. Looking forward to more collaboration in 2025!

2024 Survey Findings: How Is The "Lab Of The Future" Becoming Reality? Pistoia Alliance conducted another Lab of the Future survey as a pulse check on which technologies the industry is investing in and its progress in integrating new tech into the lab. Among 200 life sciences R&D experts spanning Europe, the Americas, and APAC, the goal of the research is: What does the industry need to make the tech of tomorrow a reality in the labs of today? Learn more about the survey results: https://lnkd.in/eCpxF-zg

Becky Upton from Pistoia Alliance explained maximizing the value of ontologies in drug development processes: 'Ontologies in Pharma: The landscape, pre-competitive development, and use-cases'. #ChemTalks #Chemaxon

Have you explored our latest white paper? It delves into how conflicting incentives hinder data sharing within and between life sciences organizations and healthcare systems. The paper offers solutions to dismantle silos, promote data exchange, and align on common objectives. The Pistoia Alliance and ZS introduce: “Are misaligned incentives obstructing improved patient outcomes in life sciences R&D? The hidden barrier to comprehensive human data integration.” This collaborative research, with insights from 25 industry leaders, examines the pathway to integrating human health data in near-real-time to drive R&D innovation. #LifeSciences #DataIntegration

The Pistoia Alliance is running a competition to find the 2025 Young Data Scientist of the Year. The award is open to all young data scientists working in life sciences. If you are a data scientist that can demonstrate the impact your work has made or if you would like to nominate a team member for this exciting award which recognises and nurtures vital emerging talent, please apply/nominate someone today, here: Young Data Scientist of the Year - Pistoia Alliance   The deadline for entries is 31 January 2025. The winner will be announced at the Pistoia Alliance’s annual London Conference on 26 March 2025 at the Royal Society of Medicine and will receive a cash prize of $1,500 as well as mentoring from an esteemed panel of judges drawn from across the global life sciences industry.  https://lnkd.in/eEENqXVH

🌍 AI in Life Sciences: A Global Challenge A recent survey by the Pistoia Alliance and Copyright Clearance Center (CCC) reveals that 85% of life science professionals are concerned about the impact of differing AI regulations on innovation and collaboration. With AI rapidly transforming the life sciences sector—from drug discovery to personalized medicine—it's crucial to address the challenges posed by the regulatory frameworks across regions. At the Pistoia Alliance, we're committed to fostering collaboration and driving solutions that help the industry navigate these complexities. By working together, we can ensure that AI continues to advance scientific breakthroughs while safeguarding ethical and responsible use. Read the full article here https://lnkd.in/dgFi_n3p Alison Anderton, Christine McCarty, Vladimir Makarov, Becky Upton, Shaun Tamblin

✴️ Realizing the Benefits of IDMP: Key Challenges Facing the Industry 💡 The majority—89%—of pharma companies recognize the long-term value of IDMP in their digitalization strategies. However, significant challenges remain, including: 🔸 a lack of standardization, 🔸 insufficient resources,  🔸 unclear data ownership,  🔸 and data quality issues.  These challenges hinder progress towards effective data integration and continue to be the major barriers toward delivering efficiency improvements. 🌟 These insights come from a new industry benchmark survey conducted by MAIN5, Accurids and the Pistoia Alliance’s IDMP-Ontology (IDMP-O) project team. The IDMP-O project aims to create a shared ontology aligned with #ISO #IDMP standards, providing a standardized framework and collaborative platform to ensure consistent adoption of IDMP. 📑 To see how your company's progress compares to industry peers, download your complimentary copy of the full benchmark report, "Accelerating Digital Transformation in Pharma with IDMP: An industry benchmark report on the status of IDMP standards implementation in Pharma and the role of the IDMP Ontology for accelerating digital transformation", here: https://lnkd.in/dMHEYVjK

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced the results of a global survey in conjunction with Copyright Clearance Center (CCC), a leader in advancing copyright, accelerating knowledge, and powering innovation, on the impact of AI and copyright legislation on pharma R&D. While 83% of life science professionals are now using generative AI in their research, there is still widespread concern about the impact of differing AI regulations on cross-border research collaboration (85%). Additionally, 42% of respondents said they don’t consider copyright before sharing or using third-party information with AI tools. The survey was conducted at the Alliance’s annual US conference held this year in Philadelphia, which gathered more than 200 industry experts to collaborate on topics such as AI regulation, harmonization of data standards, and patient-centricity. “It’s encouraging to see such an uptake in the number of researchers using Generative AI to accelerate R&D, but it’s a concern that copyright is often an afterthought. Less than half (40%) of organizations have a team or person dedicated to understanding copyright issues and AI, even though this is a complex area that requires expertise,” said Babis Marmanis, CCC Executive Vice President & CTO.